Brief: Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand
16/06/2026 21:16
BRIEF-Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand Jun 16 (Reuters) - Sonoma Pharmaceuticals Q4 operating expenses USD 2.5 million.
- Q4 gross profit USD 2.2 million
- Q4 EBITDA USD -200 thousand
- Q4 revenue USD 5.6 million
Recent news on Sonoma Pharmaceuticals
See all newsSonoma Pharmaceuticals Q1 revenue rises on US growth
Brief: Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million
Sonoma Pharmaceuticals Q4 revenue rises 48% on US growth
Brief: Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand
Brief: Sonoma Pharmaceuticals Inc - Offers Units In Public Offering For Gross Proceeds Of $5 Million - SEC Filing